[go: up one dir, main page]

NO20002487D0 - Preparat med azelainsyre - Google Patents

Preparat med azelainsyre

Info

Publication number
NO20002487D0
NO20002487D0 NO20002487A NO20002487A NO20002487D0 NO 20002487 D0 NO20002487 D0 NO 20002487D0 NO 20002487 A NO20002487 A NO 20002487A NO 20002487 A NO20002487 A NO 20002487A NO 20002487 D0 NO20002487 D0 NO 20002487D0
Authority
NO
Norway
Prior art keywords
azelaic acid
preparation
composition
presbyderma
triacylglyceride
Prior art date
Application number
NO20002487A
Other languages
English (en)
Other versions
NO327712B1 (no
NO20002487L (no
Inventor
Patrick Franke
Clemens Guenther
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27217979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002487(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20002487D0 publication Critical patent/NO20002487D0/no
Publication of NO20002487L publication Critical patent/NO20002487L/no
Publication of NO327712B1 publication Critical patent/NO327712B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20002487A 1997-11-19 2000-05-12 Azelainsyreholdig preparat og anvendelse derav NO327712B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19753044 1997-11-19
US7485098P 1998-02-12 1998-02-12
DE19808086 1998-02-20
PCT/EP1998/007370 WO1999025332A1 (de) 1997-11-19 1998-11-18 Zusammensetzung mit azelainsäure

Publications (3)

Publication Number Publication Date
NO20002487D0 true NO20002487D0 (no) 2000-05-12
NO20002487L NO20002487L (no) 2000-07-18
NO327712B1 NO327712B1 (no) 2009-09-14

Family

ID=27217979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002487A NO327712B1 (no) 1997-11-19 2000-05-12 Azelainsyreholdig preparat og anvendelse derav

Country Status (21)

Country Link
US (1) US6534070B1 (no)
EP (1) EP1032379B1 (no)
JP (1) JP3867123B2 (no)
KR (1) KR100534511B1 (no)
AT (1) ATE210438T1 (no)
AU (1) AU743437B2 (no)
BR (1) BR9814214B1 (no)
CA (1) CA2311128C (no)
CZ (1) CZ299116B6 (no)
DE (2) DE19881737D2 (no)
DK (1) DK1032379T3 (no)
ES (1) ES2169566T3 (no)
HU (1) HU226592B1 (no)
IL (1) IL136101A (no)
IS (1) IS2257B (no)
NO (1) NO327712B1 (no)
PL (1) PL202454B1 (no)
PT (1) PT1032379E (no)
SK (1) SK284338B6 (no)
TR (1) TR200001393T2 (no)
WO (1) WO1999025332A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004108143A1 (de) * 2003-06-10 2004-12-16 Schering Aktiengesellschaft Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff
US20050026982A1 (en) * 2003-06-10 2005-02-03 Soenke Johannsen Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient
ATE347367T1 (de) * 2003-10-13 2006-12-15 Zoser B Salama Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze
DE10356288B4 (de) 2003-11-28 2014-04-03 Siemens Aktiengesellschaft Röntgendetektorlade
US20060204469A1 (en) * 2005-03-09 2006-09-14 Eric Spengler Stable mixed emulsions
WO2007040598A2 (en) * 2005-09-19 2007-04-12 Combe Incorporated Stable emulsion systems with high salt tolerance
KR100861978B1 (ko) * 2007-03-22 2008-10-07 한국콜마 주식회사 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
EP2201930A1 (en) * 2008-12-23 2010-06-30 Intendis GmbH Hydrogel composition for the treatment of dermatological disorders
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
PL217786B1 (pl) * 2009-05-28 2014-08-29 P P F Hasco Lek Spółka Akcyjna Żel z kwasem azelainowym i sposób wytwarzania żelu z kwasem azelainowym
DE112010003355T5 (de) 2009-08-21 2012-07-12 Targeted Delivery Technologies Ltd. Veskuläre Formulierungen
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
GB201205642D0 (en) * 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
GB201208409D0 (en) * 2012-05-14 2012-06-27 Sequessome Technology Holdings Ltd Vesicular formulations, kits and uses
PT3316857T (pt) 2015-06-30 2021-11-03 Sequessome Tech Holdings Limited Composições multifásicas
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
CN116747147B (zh) * 2023-04-27 2025-10-17 南京市苗本堂健康管理有限公司 一种靶向祛痘的壬二酸微纳晶混悬液及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811081A1 (de) 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
ES2067255T3 (es) * 1990-11-14 1995-03-16 Oreal Compuestos anfifilos no ionicos derivados del glicerol, su procedimiento de preparacion, compuestos intermedios correspondientes y composiciones que contienen dichos compuestos.
GB9316323D0 (en) 1993-08-06 1993-09-22 Procter & Gamble Cosmetic compositions
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
AU5543294A (en) 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5547989A (en) 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US5618522A (en) * 1995-01-20 1997-04-08 The Procter & Gamble Company Emulsion compositions
UY24246A1 (es) 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado

Also Published As

Publication number Publication date
AU743437B2 (en) 2002-01-24
CA2311128C (en) 2008-01-29
AU1755199A (en) 1999-06-07
ES2169566T3 (es) 2002-07-01
SK284338B6 (sk) 2005-02-04
IS2257B (is) 2007-06-15
PT1032379E (pt) 2002-06-28
ATE210438T1 (de) 2001-12-15
US6534070B1 (en) 2003-03-18
KR20010032229A (ko) 2001-04-16
IS5484A (is) 2000-05-09
WO1999025332A1 (de) 1999-05-27
IL136101A (en) 2005-08-31
PL340631A1 (en) 2001-02-12
BR9814214A (pt) 2000-10-03
SK7082000A3 (en) 2001-06-11
PL202454B1 (pl) 2009-06-30
DE59802473D1 (de) 2002-01-24
KR100534511B1 (ko) 2005-12-08
HU226592B1 (en) 2009-04-28
JP3867123B2 (ja) 2007-01-10
CA2311128A1 (en) 1999-05-27
NO327712B1 (no) 2009-09-14
HUP0004375A2 (hu) 2001-08-28
NO20002487L (no) 2000-07-18
EP1032379B1 (de) 2001-12-12
BR9814214B1 (pt) 2010-07-13
DK1032379T3 (da) 2002-04-02
CZ20001844A3 (cs) 2000-10-11
TR200001393T2 (tr) 2000-10-23
JP2001522879A (ja) 2001-11-20
HUP0004375A3 (en) 2006-06-28
DE19881737D2 (de) 2001-03-22
CZ299116B6 (cs) 2008-04-30
EP1032379A1 (de) 2000-09-06
IL136101A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
NO20002487D0 (no) Preparat med azelainsyre
AR002974A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparación de una composición cosmética, farmacéutica y/o dermatológica para tratar las manchas rojas cutáneas de origen neurógeno, composición obtenida y procedimiento de tratamiento cosmético empleando dicho antagonista.
BR0003897A (pt) Aditivo para aumento da resistência à água de formulações cosméticas ou dermatológicas e seus usos
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
DK261490D0 (da) New pharmaceutical compound
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
BR9916860A (pt) Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
EP1090635A3 (en) Use of ferulic acid for treating hypertension
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
WO2000061171A3 (en) Uses of mammalian ox2 protein and related reagents
BR9701455A (pt) Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado
IT1306186B1 (it) Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
MY129121A (en) Composition with azelaic acid
GR77250B (no)
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
BR0015424A (pt) Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
EP1106177A4 (en) AGENTS FOR INCREASING MEDICINE ACCUMULATION IN TUMOR TISSUES
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.
AU4115100A (en) Pharmaceutical composition on the basis of erythromycin fatty acid salts for thetopical treatment of skin diseases
IT1275987B1 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche

Legal Events

Date Code Title Description
MK1K Patent expired